speb/financial-data huggingface dataset:
PHI income_statement (quarterly, 2025-03-31) — Amortization: 71000000.00
PHI cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 71000000.00
PHI cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 71000000.00
PHI income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 71000000.00
PHI cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 867000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 6671000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 3472000000.00
PHI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 216056000.00
PHI income_statement (quarterly, 2025-03-31) — Basic EPS: 41.71
PHI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 10011000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 29235000000.00
PHI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -16142000000.00
PHI cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -608000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 53815000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1603000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 13759000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14663000000.00
PHI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -39000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 4598000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Cash Financial: 9161000000.00
PHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4918000000.00
PHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -15851000000.00
PHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 24545000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -117000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -1721000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Inventory: 556000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -451000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 34000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -680000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Payable: -117000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1838000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 714000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2756000000.00
PHI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4421000000.00
PHI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2890000000.00
PHI cash_flow (quarterly, 2025-03-31) — Changes In Cash: 3776000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Common Stock: 1093000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 114937000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 74371000000.00
PHI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7830000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 59595000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Assets: 67908000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 7584000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Debt: 20165000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 27749000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 9927000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 9927000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 187788000000.00
PHI cash_flow (quarterly, 2025-03-31) — Depreciation: 13072000000.00
PHI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 13072000000.00
PHI income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 13072000000.00
PHI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 13072000000.00
PHI income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 13072000000.00
PHI income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 13001000000.00
PHI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 216056000.00
PHI income_statement (quarterly, 2025-03-31) — Diluted EPS: 41.71
PHI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 9011000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 12135000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 352000000.00
PHI income_statement (quarterly, 2025-03-31) — EBIT: 16106000000.00
PHI income_statement (quarterly, 2025-03-31) — EBITDA: 29178000000.00
PHI income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 83000000.00
PHI cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -83000000.00
PHI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -28000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 3606000000.00
PHI cash_flow (quarterly, 2025-03-31) — End Cash Position: 13759000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Financial Assets: 419000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1097000000.00
PHI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4918000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1751000000.00
PHI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 8403000000.00
PHI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 335000000.00
PHI cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -48000000.00
PHI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 48000000.00
PHI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 209000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -42720000000.00
PHI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 8281000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Goodwill: 62941000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 64454000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 49413000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 946841000000.00
PHI income_statement (quarterly, 2025-03-31) — Gross Profit: 47447000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 28000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 1714000000.00
PHI income_statement (quarterly, 2025-03-31) — Insurance And Claims: 350000000.00
PHI income_statement (quarterly, 2025-03-31) — Interest Expense: 4302000000.00
PHI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 4302000000.00
PHI income_statement (quarterly, 2025-03-31) — Interest Income: 199000000.00
PHI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 199000000.00
PHI cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -2808000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Interest Payable: 2844000000.00
PHI cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 198000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Inventory: 2747000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 398003000000.00
PHI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -15851000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Investment Properties: 5515000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 4569000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 57423000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 19087000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 33767000000.00
PHI cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 6822000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 50297000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 46231000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 262901000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 309132000000.00
PHI cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 5800000000.00
PHI cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -7845000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 52854000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1807000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 777299000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1349000000.00
PHI income_statement (quarterly, 2025-03-31) — Minority Interests: -39000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -8000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Net Debt: 269307000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -544000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income: 9025000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 9011000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 9064000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 9025000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 9025000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 11804000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 9064000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Interest Income: -4137000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
PHI cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 36000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2045000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2045000000.00
PHI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4137000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -26000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Net PPE: 357945000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -15469000000.00
PHI cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
PHI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 50993000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 422000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 35000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 12386000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 7435000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 7386000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 12386000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 49000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3606000000.00
PHI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 29788000000.00
PHI income_statement (quarterly, 2025-03-31) — Normalized Income: 9493403930.87
PHI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 24545000000.00
PHI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 29000000.00
PHI income_statement (quarterly, 2025-03-31) — Operating Income: 15595000000.00
PHI income_statement (quarterly, 2025-03-31) — Operating Revenue: 55277000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 11151000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 20165000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4171000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -42720000000.00
PHI income_statement (quarterly, 2025-03-31) — Other Gand A: 2047000000.00
PHI income_statement (quarterly, 2025-03-31) — Other Income Expense: 346000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1513000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Inventories: 384000000.00
PHI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4093000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 60196000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 69000000.00
PHI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 873000000.00
PHI income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 8006000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Properties: 15639000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1286000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 904000000.00
PHI income_statement (quarterly, 2025-03-31) — Other Taxes: 1345000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Payables: 77939000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 137534000000.00
PHI cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 369000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8407000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 510000000.00
PHI income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 14000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 510000000.00
PHI income_statement (quarterly, 2025-03-31) — Pretax Income: 11804000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PHI cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -8000000.00
PHI cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
PHI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -15534000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Raw Materials: 612000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Receivables: 32648000000.00
PHI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 7830000000.00
PHI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 13072000000.00
PHI income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 313000000.00
PHI income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 313000000.00
PHI cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -8867000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 32757000000.00
PHI income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5571000000.00
PHI cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 36000000.00
PHI cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
PHI cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 65000000.00
PHI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1148000000.00
PHI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 9429000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Share Issued: 219055775.00
PHI cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 1022000000.00
PHI cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -1022000000.00
PHI income_statement (quarterly, 2025-03-31) — Special Income Charges: -819000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 115447000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 50483000000.00
PHI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -141596069.13
PHI income_statement (quarterly, 2025-03-31) — Tax Provision: 2740000000.00
PHI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
PHI cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -899000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Assets: 626668000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 378348000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Debt: 336881000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 116796000000.00
PHI income_statement (quarterly, 2025-03-31) — Total Expenses: 39682000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 509872000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 558760000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 322084000000.00
PHI income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 34000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 11290000000.00
PHI income_statement (quarterly, 2025-03-31) — Total Unusual Items: -610000000.00
PHI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -610000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (quarterly, 2025-03-31) — Working Capital: -119880000000.00
PHI income_statement (quarterly, 2025-03-31) — Write Off: 867000000.00
PHI income_statement (quarterly, 2025-06-30) — +Operating Expense: 32163000000.00
PHI income_statement (quarterly, 2025-06-30) — +Total Revenue: 54297000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 56721000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 31215000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -598208000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -19006000000.00
PHI cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 73000000.00
PHI cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 73000000.00
PHI cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1001000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 6899000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 3331000000.00
PHI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 216437055.00
PHI income_statement (quarterly, 2025-06-30) — Basic EPS: 42.10
PHI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 13759000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 29284000000.00
PHI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17936000000.00
PHI cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -668000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 55765000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1603000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 10837000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 11623000000.00
PHI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -10174000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 3262000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Cash Financial: 7575000000.00
PHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -8406000000.00
PHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -16619000000.00
PHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 22160000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2817000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -2294000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Inventory: 264000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -115000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 19000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -3005000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Payable: -2817000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5111000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1534000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1522000000.00
PHI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4892000000.00
PHI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1537000000.00
PHI cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2865000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Common Stock: 1093000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 123758000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 83610000000.00
PHI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 7315000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 57048000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Assets: 64117000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 7869000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Debt: 22529000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 30398000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 10076000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 10076000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 174084000000.00
PHI cash_flow (quarterly, 2025-06-30) — Depreciation: 12971000000.00
PHI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 13115000000.00
PHI income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 13042000000.00
PHI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13115000000.00
PHI income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 13042000000.00
PHI income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 13042000000.00
PHI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 216437055.00
PHI income_statement (quarterly, 2025-06-30) — Diluted EPS: 42.10
PHI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 9112000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 2026000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 54000000.00
PHI income_statement (quarterly, 2025-06-30) — EBIT: 14819000000.00
PHI income_statement (quarterly, 2025-06-30) — EBITDA: 27934000000.00
PHI income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -1000000.00
PHI cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -31000000.00
PHI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -57000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 3879000000.00
PHI cash_flow (quarterly, 2025-06-30) — End Cash Position: 10837000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Financial Assets: 393000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1101000000.00
PHI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -8406000000.00
PHI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4224000000.00
PHI cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 383000000.00
PHI cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -998000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -42996000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Goodwill: 62941000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 64396000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 50221000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 965618000000.00
PHI income_statement (quarterly, 2025-06-30) — Gross Profit: 46982000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 8000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 540000000.00
PHI cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -3686000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Interest Payable: 2514000000.00
PHI cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 163000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Inventory: 2473000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 415571000000.00
PHI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -16619000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Investment Properties: 5535000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 4432000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 57423000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 19165000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 33826000000.00
PHI cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 13100000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 52199000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 47896000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 269284000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 317180000000.00
PHI cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 13100000000.00
PHI cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -6818000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 52991000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 1831000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 784630000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1143000000.00
PHI income_statement (quarterly, 2025-06-30) — Minority Interests: -2000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -107000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Net Debt: 280976000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -862000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income: 9112000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 9112000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9114000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 9112000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 9112000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 11874000000.00
PHI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9114000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 263000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 6282000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 6282000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -828000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Net PPE: 367410000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -16270000000.00
PHI cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
PHI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 59872000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 361000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Accrued Expenses: 43000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 10906000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 7120000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 7073000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 10906000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 47000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3879000000.00
PHI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 28935000000.00
PHI income_statement (quarterly, 2025-06-30) — Normalized Income: 9880326932.79
PHI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 22160000000.00
PHI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1130000000.00
PHI income_statement (quarterly, 2025-06-30) — Operating Income: 14819000000.00
PHI income_statement (quarterly, 2025-06-30) — Operating Revenue: 54297000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 10573000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 22529000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4050000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -42996000000.00
PHI income_statement (quarterly, 2025-06-30) — Other Income Expense: -2946000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1455000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Inventories: 2473000000.00
PHI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 4265000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 59078000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 71000000.00
PHI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1944000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Properties: 15895000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1326000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 786000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Payables: 67131000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 124179000000.00
PHI cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: 378000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 5381000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 450000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 510000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 510000000.00
PHI income_statement (quarterly, 2025-06-30) — Pretax Income: 11874000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PHI cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -107000000.00
PHI cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
PHI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -17268000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Receivables: 32541000000.00
PHI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 7242000000.00
PHI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13115000000.00
PHI cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -6818000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 41854000000.00
PHI cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 263000000.00
PHI cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 998000000.00
PHI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 19121000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Share Issued: 219055775.00
PHI cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
PHI cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
PHI income_statement (quarterly, 2025-06-30) — Special Income Charges: -1001000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 124268000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 59362000000.00
PHI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -232673067.21
PHI income_statement (quarterly, 2025-06-30) — Tax Provision: 2760000000.00
PHI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
PHI cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -2073000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Assets: 629619000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 393552000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Debt: 347578000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 125411000000.00
PHI income_statement (quarterly, 2025-06-30) — Total Expenses: 39478000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 504208000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 565502000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 330124000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 8330000000.00
PHI income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1001000000.00
PHI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1001000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 3000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 6505000000.00
PHI balance_sheet (quarterly, 2025-06-30) — Working Capital: -109967000000.00
PHI income_statement (quarterly, 2025-06-30) — Write Off: 1001000000.00
PHI income_statement (quarterly, 2025-09-30) — +Operating Expense: 34674000000.00
PHI income_statement (quarterly, 2025-09-30) — +Total Revenue: 53709000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 49778000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 30015000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -609900000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -17856000000.00
PHI cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 983000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 6316000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 3160000000.00
PHI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 216552155.00
PHI income_statement (quarterly, 2025-09-30) — Basic EPS: 32.02
PHI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 10837000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 36520000000.00
PHI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -18015000000.00
PHI cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -789000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 60755000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1603000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10092000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10382000000.00
PHI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -10363000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 3215000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6877000000.00
PHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -12840000000.00
PHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -17114000000.00
PHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 29060000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2055000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -2515000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Inventory: 317000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 832000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -10000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -2388000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Payable: 2055000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -460000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -401000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2158000000.00
PHI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 48000000.00
PHI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 2175000000.00
PHI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -894000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Common Stock: 1093000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 119816000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 72977000000.00
PHI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 6699000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 55828000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Assets: 61945000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 8667000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Debt: 17406000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 26073000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 9437000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 9437000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 163382000000.00
PHI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 15633000000.00
PHI income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 15633000000.00
PHI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 15633000000.00
PHI income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 15633000000.00
PHI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 216552155.00
PHI income_statement (quarterly, 2025-09-30) — Diluted EPS: 32.02
PHI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 6934000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 2074000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 127000000.00
PHI income_statement (quarterly, 2025-09-30) — EBIT: 12336000000.00
PHI income_statement (quarterly, 2025-09-30) — EBITDA: 27969000000.00
PHI income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 0.00
PHI cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -199000000.00
PHI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 149000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 2555000000.00
PHI cash_flow (quarterly, 2025-09-30) — End Cash Position: 10092000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Financial Assets: 570000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1086000000.00
PHI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -12840000000.00
PHI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 11045000000.00
PHI cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -2129000000.00
PHI cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 60000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -43486000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Goodwill: 62941000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 64342000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 47871000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 980877000000.00
PHI income_statement (quarterly, 2025-09-30) — Gross Profit: 47010000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 737000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1042000000.00
PHI cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -2936000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Interest Payable: 2939000000.00
PHI cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 173000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Inventory: 2172000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 417352000000.00
PHI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -17114000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Investment Properties: 5536000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 4246000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 57497000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 19961000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 33290000000.00
PHI cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 14350000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 60344000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 52088000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 280130000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 332218000000.00
PHI cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 14250000000.00
PHI cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -13552000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 53251000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 1861000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 793374000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1166000000.00
PHI income_statement (quarterly, 2025-09-30) — Minority Interests: -23000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 531000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Net Debt: 287444000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 1511000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income: 6934000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 6934000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 6957000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 6934000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 6934000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 9040000000.00
PHI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 6957000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 177000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 798000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 698000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -339000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Net PPE: 370977000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -17206000000.00
PHI cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 100000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 55984000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 335000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 1749000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 10089000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 6231000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 6154000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 10089000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 77000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 2555000000.00
PHI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 28953000000.00
PHI income_statement (quarterly, 2025-09-30) — Normalized Income: 7691266371.68
PHI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 29060000000.00
PHI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -376000000.00
PHI income_statement (quarterly, 2025-09-30) — Operating Income: 12336000000.00
PHI income_statement (quarterly, 2025-09-30) — Operating Revenue: 53709000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 10973000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 17406000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 4229000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -43486000000.00
PHI income_statement (quarterly, 2025-09-30) — Other Income Expense: -3296000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1401000000.00
PHI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 4417000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 58265000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 68000000.00
PHI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -2312000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Properties: 17662000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1350000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 290000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Payables: 62008000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 117836000000.00
PHI cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 381000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 5807000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 450000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 510000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 510000000.00
PHI income_statement (quarterly, 2025-09-30) — Pretax Income: 9040000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PHI cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -69000000.00
PHI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
PHI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -17226000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Receivables: 31365000000.00
PHI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 6699000000.00
PHI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 15633000000.00
PHI cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -13552000000.00